Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes after Percutaneous Coronary Intervention in Acute STEMI Patients: A Randomized Double Blind Clinical Trial

Impact of Allopurinol Pretreatment on Coronary Blood Flow and Revascularization Outcomes after Percutaneous Coronary Intervention in Acute STEMI Patients: A Randomized Double Blind Clinical Trial

INTRODUCTION: The generation of reactive oxygen species, which is induced by the activation of the xanthine oxidase (XO) enzymatic system, is one of the primary causes of ischemia-reperfusion injury for an ischemic heart. Allopurinol, as an XO inhibitor, plays an inhibitory role in free radical prod...

Full description

Bibliographic Details
Main Authors:	Mohammad Kermani-Alghoraishi, MD, Hamid Sanei, Kiyan Heshmat-Ghahdarijani, Rahil Ghahramani, Mehrdad Honarvar, Masoumeh Sadeghi
Format:	Article
Language:	English
Published:	Vesnu Publications 2023-11-01
Series:	ARYA Atherosclerosis
Subjects:	allopurinol percutaneous coronary intervention stemi timi flow
Online Access:	https://arya.mui.ac.ir/article_30948_af4b68a6ccf1d0073b59c970405568be.pdf

Similar Items

The Effect of High-dose Allopurinol Pretreatment on Inflammatory Biomarkers and Post-revascularization Coronary Blood Flow in Non-STEMI Patients: A Randomized Double Blind Clinical Trial
by: Hamid Sanei, et al.
Published: (2023-07-01)

Predictors of suboptimal coronary blood flow after primary angioplasty and its implications on short-term outcomes in patients with acute anterior STEMI
by: Karim Elakabawi, et al.
Published: (2020-08-01)

Interplay between Oxidative Stress and Platelet Activation in Coronary Thrombus of STEMI Patients
by: Camilla Calvieri, et al.
Published: (2018-07-01)

Does opioid addiction influence clinical and angiographic outcomes in STEMI patients undergoing emergency PCI?
by: Afshin Amirpour, et al.
Published: (2023-01-01)

Prognostic impact of pre-interventional culprit artery thrombolysis in myocardial infarction (TIMI) flow in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention
by: Raouf Shaaban, et al.
Published: (2022-06-01)

Effect of Post Dilatation on TIMI Flow in Patients Undergoing Primary Percutaneous Coronary Intervention
by: Muhammad Amad Abbasi, et al.
Published: (2022-11-01)

Outcome of manual thrombus aspiration for patients undergoing primary PCI for acute STEMI showing large thrombus burden
by: Ehab Mohamed Elfekky, et al.
Published: (2021-01-01)

Allopurinol
by: 982 SIRIM

Clinical and angiographic characteristics of patients with STEMI and confirmed diagnosis of COVID-19: an experience of Tanta University Hospital
by: Ahmed Alaarag, et al.
Published: (2020-10-01)

The Effects of Percutaneous Coronary Intervention on the Flow in Acute Coronary Syndrome Patients—Geometry in Focus
by: Agnes Orsolya Racz, et al.
Published: (2022-07-01)

Temporal trends in the pre-procedural TIMI flow grade among patients with ST- segment elevation myocardial infarction – From the ACSIS registry
by: Nili Schamroth Pravda, et al.
Published: (2021-10-01)

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting
by: Tejas P. Singh, et al.
Published: (2018-07-01)

Complete Revascularization and Survival in STEMI
by: Miha Sustersic, et al.
Published: (2021-09-01)

Effect of high-intensity statin preloading on TIMI flow in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
by: Ahmed Shawky Elserafy, et al.
Published: (2020-07-01)

Allopurinol: Sorrow to the marrow
by: U R Raaju, et al.
Published: (2020-01-01)

Agranulocytosis: an adverse effect of allopurinol treatment
by: Elisa Mari, et al.
Published: (2013-03-01)

Allopurinol prophylactic therapy and the prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography: A prospective randomized controlled trial
by: Leili Iranirad, et al.
Published: (2017-10-01)

Implementation of a Night Service of Helicopter Transportation to Reduce the Time to Revascularization in STEMI Patients in a Mountainous Region: Impact on Outcomes
by: Filippo Zilio, et al.
Published: (2022-08-01)

Predictors of 30-day Mortality in ST-Elevation Myocardial Infarction (STEMI) Patients
by: Eka Ginanjar, et al.
Published: (2019-11-01)

The effects of allopurinol mouthwash in the prevention of chemotherapy-induced stomatitis
by: Shabanloei R, et al.
Published: (2007-10-01)

COMPLETE revascularization after STEMI? Sure, go ahead
by: José López-Sendón, et al.
Published: (2019-08-01)

Clinical Study on efficacy of allopurinol in patients with acute coronary syndrome and its functional mechanism
by: Ying Huang, et al.
Published: (2017-09-01)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
by: Luca Grancini, et al.
Published: (2023-03-01)

The role of allopurinol′s timing in the ischemia reperfusion injury of small intestine
by: Konstantinos Sapalidis, et al.
Published: (2013-01-01)

Comparison of Efficacy of Febuxostat with Allopurinol in Lowering Serum Urate Levels
by: Muhammad Osama Osama
Published: (2017-06-01)

Dress syndrome secondaire à l'allopurinol
by: Youssef Zemmez, et al.
Published: (2018-06-01)

A Rare Case of Pyopneumopericardium Diagnosed by Coronary Angiography in a Patient Presented as STEMI
by: Stoica Adrian, et al.
Published: (2024-02-01)

Allopurinol Induction on Histopathological Structure of the Liver in Male Mice (Mus musculus)
by: Dian Fita Lestari, et al.
Published: (2022-11-01)

Allopurinol-induced DRESS syndrome mimicking biliary obstruction
by: Hyung Gyu Choi, et al.
Published: (2014-03-01)

Allopürinol'ün Neden Olduğu ve Seftriakson Tarafından Tetiklenen Yeni Bir DRESS Sendromu Olgusu
by: Muhammet Kızmaz, et al.
Published: (2019-06-01)

A randomized controlled study of allopurinol mouthwash in the prevention of 5-fluorouracil-induced oral mucositis
by: P Kaewmanee, et al.
Published: (2009-01-01)

Comparative Study of Allopurinol and Uralyt-4 in patients with Hyperuricemia in Diyala Governorate.
by: Zuhir M. Hussein, et al.
Published: (2014-04-01)

Allopurinol effects on diastolic dysfunction in ESRD patients with hyperuricemia
by: Sattarzade Badkoobeh R, et al.
Published: (2011-01-01)

The pattern of allopurinol prescription in a university hospital practice
by: Sahar Ahmed Saad, et al.
Published: (2020-09-01)

Isolated coronary artery ectasia presenting as inferior-posterior STEMI—a case-based state-of-the-art review of the current literature
by: Giucă Adrian, et al.
Published: (2023-12-01)

Complete versus culprit-vessel only revascularization in STEMI: An updated meta-analysis of randomized control trials☆
by: Kartik Gupta, et al.
Published: (2020-04-01)

Heart failure, oxidative stress and allopurinol
by: Paolo Biagi, et al.
Published: (2005-03-01)

Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
by: Manuela Gizzarelli, et al.
Published: (2023-06-01)

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

The effect of graft application and allopurinol treatment on calvarial bone defect in rats
by: Nihat Laçin, et al.
Published: (2019-03-01)